PhRMA Priorities Include Insurance Advocacy And Public Education On Patent Issues
The association’s incoming chair, Bristol CEO Peter Dolan, is launching a five-year planning process.
The association’s incoming chair, Bristol CEO Peter Dolan, is launching a five-year planning process.